MICRO-X LIMITED(MX1)

The suspension of trading in the securities of Micro-X Limited will be lifted immediately following the release by MX1 of an announcement regarding an equity raising.

The company has successfully completed a $3.3m institutional placement and accelerated entitlement offer for new shares in its cold cathode x-ray technology. The placement and offer price, which is 7.0 cents per share, raised a total of $3.3m, with support from two substantial shareholders. The retail offer will open on 13 February 2025.

The company is launching an accelerated non-renounceable pro-rata entitlement offer of new fully paid ordinary shares to raise up to A$4 million. Eligible shareholders will be invited to subscribe for 1 New Share for every 10 existing shares held on February 10, 2025, at an issue price of A$0.07 per New Share. The company has not disclosed the offer to investors and has complied with the Corporations Act provisions.

The company raises $6.0m for medical imaging and mobile X-ray products, with a placement to investors and a 1 for 10 entitlement offer to existing shareholders.

The company has entered a strategic partnership with Malaysian hi-tech company Billion Prima for a $3.2m scanner commercialisation project. The partnership will provide a 15% premium to the last traded price of 7.8c per share, with Billion Prima receiving exclusive rights to manufacture and sell the unit in South-East Asia.

The company has rescheduled its Quarterly Investor Conference Call for February 2025 due to the company's capital raising preparations and the need for a later date.

The securities of Micro-X Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of MX1, pending the release of an announcement regarding an equity raising.

The suspension of trading in the securities of Micro-X Limited will be lifted immediately following the release by MX1 of an announcement regarding a capital raising.

The company has received commitments totalling approximately $16.5 million for new fully paid ordinary shares in the company at 20 cents per share. The placement was targeted to raise $12 million to $15 million and the company reserved the right to accept oversubscriptions in the placement. As the placement was well oversubscribed the company increased the placement by 10% to $16.5 million.

Following a review by the ASX of the Company's AGM Notice of Meeting, the ASX determined that the Convertible Loan Agreement with Thales AVS France SAS completed on the 2 July 2019 comprises a 'convertible security' under the Listing Rules and as such would utilise Micro-X's placement capacity under Listing Rule 7.1. Micro-X and Thales have now amended the Loan Agreement so that the convertible security under the Loan Agreement does not take effect unless and until it has been approved by Micro-X shareholders for the purposes of Listing Rule 7.1. A shareholder meeting to approve the convertible security is proposed to be held by 31 December 2019. ASX has confirmed that, given the change to the Loan Agreement, the Company is not in breach of Listing Rule 7.1. Micro-X has used the period of trading halt and suspension to address this issue with Thales and ASX. These steps were a precursor to launching a capital raising and Morgans Corporate Limited are appointed as Lead Manager. An announcement regarding the capital raising is expected to be made pre-market open on Tuesday 19 November 2019.

The voluntary suspension will remain in place until the earlier of an announcement by MX1 in respect of the review of the company's current capital management and a potential capital raising or the commencement of normal trading on 18 November 2019.

The securities of Micro-X Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of MX1, pending the release of an announcement regarding its current capital management and a potential capital raising.

The suspension of trading in the securities of Micro-X Limited will be lifted immediately, following the release by MX1 of an announcement regarding an application lodged with the Federal Court seeking an extension of time to lodge a cleansing notice.

The company releases a cleansing notice.

The e Federal Court yesterday made orders extending the period of time in which a Cleansing Notice may be lodged in relation to the issue of placement shares announced on 24 December 2018. The Cleansing Notice may be lodged with the ASX within two business days of the Court orders.

The securities of Micro-X Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of MX1, pending the release of an announcement regarding an application lodged with the Federal Court seeking an extension of time to lodge a cleansing notice.

The securities of Micro-X Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

The company announces the successful fully subscribed private placement of 50,000 unsecured mandatorily convertible notes to raise A$5,000,000.

The securities of Micro-X Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company.

listed entity carried for record purposes only